DURALGINA

Generic: ACETAMINOPHEN

Manufacturer: Aaa Pharmaceutical, Inc.

Nonsteroidal Anti-inflammatory Drug [EPC]Corticosteroid [EPC]Benzodiazepine [EPC]Proton Pump Inhibitor [EPC]Vitamin C [EPC]
239,317
Total Reports
147,129
Serious Reports
46,895
Death Reports
30
Reported Reactions
Death Report Ratio: High (19.60%)

Patient Demographics

Male
78,887
Female
130,725

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for DURALGINA.

# Reaction Reports % of Total
1 OFF LABEL USE 21,661
6.0%
2 FATIGUE 19,923
5.5%
3 DRUG INEFFECTIVE 17,778
4.9%
4 PAIN 17,731
4.9%
5 NAUSEA 17,118
4.8%
6 HEADACHE 16,278
4.5%
7 TOXICITY TO VARIOUS AGENTS 14,610
4.1%
8 DYSPNOEA 14,171
3.9%
9 ARTHRALGIA 14,075
3.9%
10 PYREXIA 13,943
3.9%
11 VOMITING 13,598
3.8%
12 DIARRHOEA 13,031
3.6%
13 RASH 12,156
3.4%
14 INFUSION RELATED REACTION 10,763
3.0%
15 PNEUMONIA 10,702
3.0%
16 MALAISE 9,974
2.8%
17 CONDITION AGGRAVATED 9,501
2.6%
18 DIZZINESS 9,376
2.6%
19 ASTHENIA 9,359
2.6%
20 PRURITUS 9,277
2.6%
21 NASOPHARYNGITIS 8,947
2.5%
22 DEATH 8,930
2.5%
23 JOINT SWELLING 8,783
2.4%
24 RHEUMATOID ARTHRITIS 8,704
2.4%
25 WEIGHT INCREASED 8,448
2.3%
26 SINUSITIS 8,283
2.3%
27 HYPERTENSION 8,204
2.3%
28 FALL 8,189
2.3%
29 HYPERSENSITIVITY 8,051
2.2%
30 COMPLETED SUICIDE 7,992
2.2%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.